Chronic Fatigue Syndrome Trial, Recruiting NCT07426991 Sponsor: Heinrich-Heine University, Duesseldorf Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT07426991
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 79 years old (inclusive)
  • You have adequate hearing and vision (with glasses or hearing aids if needed) to complete thinking and memory tests
  • You speak and understand German well enough to take part in the study assessments
  • You are able to understand the study and give your written agreement to participate
  • You have been diagnosed with Multiple Sclerosis (MS) according to specific medical guidelines from 2017 (for the MS group)
  • You have been referred for a sleep assessment and experience at least mild fatigue, measured by a score of 43 or more on a specific fatigue questionnaire called the FSMC (for the MS group)
  • You have been referred for a sleep assessment for any reason (for the comparison/control group)

Who may not be able to join:

  • You are not willing or not able to provide signed consent to take part in the study
  • You are younger than 18 or older than 79 years old
  • You have another neurological condition alongside MS, unless that condition is migraine
  • You are taking medications that can affect sleep study results, such as benzodiazepines (confirm with trial site for a full list of affected medications)
  • You have hearing or vision problems that cannot be corrected, or your German language skills are not sufficient to reliably complete the thinking and memory tests

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4917622970340

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Heinrich-Heine University, Duesseldorf
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
1 January 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Severity of Fatigue (subjective fatigue); Severity of Fatigue (cognitive fatigability); Severity of Fatigue (physical fatigability); Sleep disorders according to AASM criteria; Verbal Learning and Memory Test (VLMT); Symbol Digit Modalities Test (SDMT); Brief Visuospatial Memory Test - Revised (BVMT-R)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov